6328-29-6 Usage
General Description
2-[(4-aminophenyl)sulfonylamino]pentanedioic acid, also known as sulbactam, is a synthetic penicillinase inhibitor used in combination with certain antibiotics to enhance their effectiveness against resistant bacteria. It works by inhibiting the enzymes that some bacteria produce to deactivate certain antibiotics, thereby allowing the antibiotics to work more effectively against the bacteria. Sulbactam is often used in combination with ampicillin or other penicillin antibiotics to treat various bacterial infections, such as respiratory tract infections, skin and soft tissue infections, and urinary tract infections. It is a white to off-white crystalline powder that is soluble in water and has a molecular formula of C8H10NNaO5S. Sulbactam is typically administered by injection and is considered safe and effective for the treatment of bacterial infections when used as directed by a healthcare professional.
Check Digit Verification of cas no
The CAS Registry Mumber 6328-29-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,2 and 8 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 6328-29:
(6*6)+(5*3)+(4*2)+(3*8)+(2*2)+(1*9)=96
96 % 10 = 6
So 6328-29-6 is a valid CAS Registry Number.
InChI:InChI=1/C11H14N2O6S/c12-7-1-3-8(4-2-7)20(18,19)13-9(11(16)17)5-6-10(14)15/h1-4,9,13H,5-6,12H2,(H,14,15)(H,16,17)
6328-29-6Relevant articles and documents
Possible antineoplastic agents, part XVII: Synthesis, antitumor and antiangiogenic study of few bioisosteres of thalidomide metabolites
Sen,Sarker,Ghosh,Mishra,Saha,Goswami,Gupta,De
, p. 1872 - 1878 (2012/09/22)
Two series of bioisostere of thalidomide metabolites and their cyclized variants were designed, synthesized and characterized. In vivo antitumor activity was studied on EAC in swiss albino mice. Cytotoxicity study was carried out on HUVEC and Vero cell lines by MTT assay method. Antiangiogenic activity on Ehrlich ascites tumor (EAT) was investigated studying inhibition of formation of micro vessels by identification of CD31 antigen through immunohistochemistry. One molecule has exhibited both antitumor and antiangiogenic activity but there is no significant toxic effect on normal cell.
